Form 4: Guardant Health Executive Granted Stock Options and Restricted Stock Units

Guardant Health's Chief Information Officer, Kumud Kalia, received stock options and restricted stock units as part of a compensation package.

Summary

• Kumud Kalia, Chief Information Officer of Guardant Health, was granted stock options for 35,721 shares at an exercise price of $28.61 on November 8, 2024.
• These stock options vest over a three-year period, with 33% vesting on October 1, 2025, and the remaining 67% vesting monthly over the subsequent two years.
• Kalia also received 23,814 restricted stock units (RSUs) on the same date.
• The RSUs also vest over a three-year period, with 33% vesting on October 1, 2025, and the remaining 67% vesting quarterly over the subsequent two years.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns executive interests with shareholder value. There are no negative implications.

Positives

• The grant of stock options and RSUs aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

This type of equity grant is a common practice in the technology and biotechnology industries to attract and retain key executives.

Comparison to Industry Standards

• Equity grants are a standard component of executive compensation packages in the biotech industry, often including a mix of stock options and restricted stock units.
• Vesting schedules of three years with a cliff vest after one year followed by monthly or quarterly vesting are typical for these types of grants.
• Companies like Illumina, Exact Sciences, and Myriad Genetics also use similar equity-based compensation strategies for their executives.

Stakeholder Impact

• Shareholders may view this as a positive sign of aligning management interests with company performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, restricted stock units, executive compensation, vesting, Guardant Health, Kumud Kalia, equity